Literature DB >> 26476728

Vertebral lesion distribution in multiple myeloma--assessed by reduced-dose whole-body MDCT.

Georg Bier, Christopher Kloth, Christoph Schabel, Malte Bongers, Konstantin Nikolaou, Marius Horger.   

Abstract

OBJECTIVE: To observe the distribution and potential distribution patterns of osteolytic and sclerotic vertebral involvement in a representative collective of multiple myeloma patients.
MATERIALS AND METHODS: A total of 66 consecutive patients with a diagnosis of multiple myeloma at initial diagnosis or during follow-up were examined by multidetector reduced-dose computed tomography to evaluate the distribution of bone lesions along the spine with focus on size, location, and lesion character. Confirmation of diagnosis was performed by comparison to follow-up computed tomography or magnetic resonance tomography. If >50% of all detected malignant lesions occurred in one spinal segment, the distribution pattern was called cervical, thoracic, lumbar, or sacral, otherwise a "mixed" pattern was classified.
RESULTS: Of a total number of 933 osseous spine lesions, 632 (67.7%) were classified as malignant (98.9% of them osteolytic) and 293 (31.5%) as benign. The distribution pattern analysis yielded two patients (3.8%) with a cervical, 26 (50%) with a thoracic, 4 (7.7%) with a lumbar, one (1.9%) with a sacral pattern, and 19 cases (36.6%) showed a mixed distribution pattern. Segment-wise, the mean lesion size was 6.52 ± 2.76 mm (cervical), 8.97 ± 5.43 mm (thoracic), 11.97 ± 7.11 mm (lumbar), and 17.5 ± 16.465 (sacral), whilst, related to the vertebra size, the lesion/vertebra size ratio is decreasing through the whole spine beginning from the top.
CONCLUSIONS: Multiple myeloma bone lesions occur preferably and are larger in the thoracic and lumbar spine. Moreover, a specific distribution pattern is present in about 60%.

Entities:  

Mesh:

Year:  2016        PMID: 26476728     DOI: 10.1007/s00256-015-2268-4

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  23 in total

1.  Distribution of proliferating bone marrow in adult cancer patients determined using FLT-PET imaging.

Authors:  James A Hayman; Jason W Callahan; Alan Herschtal; Sarah Everitt; David S Binns; Rod J Hicks; Michael Mac Manus
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-05-14       Impact factor: 7.038

Review 2.  Bone disease in multiple myeloma.

Authors:  P I Croucher; J F Apperley
Journal:  Br J Haematol       Date:  1998-12       Impact factor: 6.998

3.  Bisphosphonate therapy in multiple myeloma in preventing vertebral collapses: preliminary report.

Authors:  Francesco C Tamburrelli; L Proietti; L Scaramuzzo; V De Stefano; C A Logroscino
Journal:  Eur Spine J       Date:  2012-03-21       Impact factor: 3.134

Review 4.  Multiple myeloma associated with diffuse osteosclerotic bone lesions: a clinical entity distinct from osteosclerotic myeloma (POEMS syndrome).

Authors:  M Q Lacy; M A Gertz; C A Hanson; D J Inwards; R A Kyle
Journal:  Am J Hematol       Date:  1997-12       Impact factor: 10.047

5.  Percutaneous vertebroplasty in multiple myeloma: prospective long-term follow-up in 106 consecutive patients.

Authors:  Giovanni Carlo Anselmetti; Antonio Manca; Filippo Montemurro; Joshua Hirsch; Gabriele Chiara; Giovanni Grignani; Fabrizio Carnevale Schianca; Antonio Capaldi; Delia Rota Scalabrini; Elena Sardo; Felicino Debernardi; Gabriella Iussich; Daniele Regge
Journal:  Cardiovasc Intervent Radiol       Date:  2011-02-09       Impact factor: 2.740

6.  Vertebroplasty in multiple myeloma: outcomes in a large patient series.

Authors:  R J McDonald; A T Trout; L A Gray; A Dispenzieri; K R Thielen; D F Kallmes
Journal:  AJNR Am J Neuroradiol       Date:  2008-01-17       Impact factor: 3.825

7.  Vertebroplasty for pain relief and spinal stabilization in multiple myeloma.

Authors:  Flavio Tancioni; Martin Lorenzetti; Pierina Navarria; Andrea Nozza; Luca Castagna; Paolo Gaetani; Enrico Aimar; Daniel Levi; Antonio Di Ieva; Patrizia Pisano; Armando Santoro; Marta Scorsetti; Riccardo Rodriguez y Baena
Journal:  Neurol Sci       Date:  2010-04       Impact factor: 3.307

8.  Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.

Authors: 
Journal:  Br J Haematol       Date:  2003-06       Impact factor: 6.998

9.  Magnetic resonance imaging pattern of bone marrow involvement as a new predictive parameter of disease progression in newly diagnosed patients with multiple myeloma eligible for autologous stem cell transplantation.

Authors:  Moo-Kon Song; Joo-Seop Chung; Je-Jung Lee; Chang-Ki Min; Jae-Sook Ahn; Sang-Min Lee; Dong-Yeop Shin; Sung-Hwa Bae; Junshik Hong; Gyeong-Won Lee; In-Sook Lee; Ho-Jin Shin
Journal:  Br J Haematol       Date:  2014-03-15       Impact factor: 6.998

Review 10.  [Modern imaging techniques in patients with multiple myeloma].

Authors:  P Bannas; N Kröger; G Adam; T Derlin
Journal:  Rofo       Date:  2012-11-29
View more
  1 in total

Review 1.  Whole-body MRI, dynamic contrast-enhanced MRI, and diffusion-weighted imaging for the staging of multiple myeloma.

Authors:  Julie C Dutoit; Koenraad L Verstraete
Journal:  Skeletal Radiol       Date:  2017-03-13       Impact factor: 2.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.